1. Age does not influence efficacy of ramucirumab in advanced gastric cancer: Subgroup analyses of REGARD and RAINBOW. Issue 4 (1st February 2018) Authors: Muro, Kei; Cho, Jae Yong; Bodoky, Gyorgy; Goswami, Chanchal; Chao, Yee; dos Santos, Lucas V; Shimada, Yasuhiro; Topuzov, Eldar; Van Cutsem, Eric; Tabernero, Josep; Zalcberg, John; Chau, Ian; Cascinu, Stefano; Cheng, Rebecca; Hsu, Yanzhi; Emig, Michael; Orlando, Mauro; Fuchs, Charles Journal: Journal of gastroenterology and hepatology Issue: Volume 33:Issue 4(2018) Page Start: 814 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Tumor Response and Symptom Palliation from RAINBOW, a Phase III Trial of Ramucirumab Plus Paclitaxel in Previously Treated Advanced Gastric Cancer. (23rd December 2020) Authors: Cascinu, Stefano; Bodoky, György; Muro, Kei; Van Cutsem, Eric; Oh, Sang Cheul; Folprecht, Gunnar; Ananda, Sumitra; Girotto, Gustavo; Wainberg, Zev A.; Miron, Maria Luisa Limon; Ajani, Jaffer; Wei, Ran; Liepa, Astra M.; Carlesi, Roberto; Emig, Michael; Ohtsu, Atsushi Journal: Oncologist Issue: Volume 26:Number 3(2021) Page Start: e414 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗